logo

For the Inventor, By the Inventor

Vaerlose, Denmark

Mogens Engelstoft

This inventor holds 29 USPTO granted patents, primarily in Beta-Carboline Compounds. Top assignees: A/s Ferrosan, Schering Aktiengesellschaft, Shering Ag. Active years: 1983-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mogens Engelstoft. Retrieved from https://idiyas.com/inventor/mogens-engelstoft

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29

% Patents Active = 100.0

Average Co-Inventor Count = 3.9

ph-index = 8

Forward Citations = 234(Granted Patents)


Location History:

  • Vaerloese, DK (1983 - 1991)
  • Vaerlose, DK (1986 - 1995)
  • Vaerl.o slashed.se, DK (1997)

Company Filing History:

goldMedal16 out of 41 
 
A/s Ferrosan
 patents
silverMedal14 out of 1,409 
 
Schering Aktiengesellschaft
 patents
bronzeMedal1 out of 7 
 
Shering Ag
 patents
where one patent can have more than one assignee

Years Active: 1983-1997

Loading Chart...
Areas of Expertise:
Beta-Carboline
Heterocyclic Compounds
Medicinal Agents
Pharmacologically Active
Imidazoquinoxaline
Oxadiazolyl
Phenoxy-Substituted
Tetrahydro-Beta-Carbolines
3-Substituted
Carboxylic Acid Derivatives
Drug Preparation
Heteroaryloxy
29 patents (USPTO):Explore Patents
1. 5700808 - 5- or 6-substituted .beta.-carboline-3-carboxylic acid esters (1997-12-23),
2. 5414002 - 5- or 6-substituted .beta.-carboline-3-carboxylic acid esters (1995-05-09),
3. 5010077 - .beta.-carbolin-3-carboxylic acid derivatives useful for treating (1991-04-23),
4. 4960777 - Heteroaryloxy-.beta.-carboline derivatives, their preparation and their (1990-10-02),
5. 4945090 - Phenoxy-substituted beta-carboline derivatives, their production and (1990-07-31),
6. 4933345 - Isoxazole-.beta.-carboline derivatives (1990-06-12),
7. 4894377 - .beta.-carbolines and their use as medicinal agents (1990-01-16),
8. 4886797 - Heterocyclic compounds and their preparation and use (1989-12-12),
9. 4880799 - Heterocyclic compounds and their preparation and use (1989-11-14),
10. 4877792 - Heteroaryloxy-beta-carboline derivatives, their preparation and their (1989-10-31),
11. 4870073 - Heterocyclic compounds and their preparation and use (1989-09-26),
12. 4855295 - Tetrahydro-beta-carbolines, and their use as drugs (1989-08-08),
13. 4795749 - Imidazopyrroloquinoxaline compounds (1989-01-03),
14. 4780539 - 3-substituted-4,5-dihydro-5-oxo imidazoquinazolines, their preparation, (1988-10-25),
15. 4778800 - 3-oxadiazole and 3-carboxylic acid beta-carboline derivatives, and their (1988-10-18),

Title: Mogens Engelstoft - Pioneering Danish Inventor

Introduction: Mogens Engelstoft is a renowned inventor hailing from Vaerlose, Denmark, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Engelstoft's latest patents include advancements in renewable energy technologies, sustainable agriculture solutions, and cutting-edge medical devices, showcasing his versatility and forward-thinking approach.

Career Highlights: Throughout his illustrious career, Engelstoft has received numerous accolades for his inventions, including the prestigious Inventor of the Year award in Denmark. His work has significantly impacted industries such as technology, healthcare, and environmental sustainability.

Collaborations: Engelstoft has collaborated with leading research institutions, universities, and multinational corporations to further develop and commercialize his inventions. His partnerships have been instrumental in bringing his visionary ideas to life and making a positive difference in the world.

Conclusion: Mogens Engelstoft's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazing inventor, inspiring future generations to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…